Abstract
Background: Marfan syndrome (MFS) is a rare disease caused by a defect in the fibrillin-1 gene (FBN1), with potentially severe cardiovascular manifestations. MFS patients are particularly susceptible to a progressive aortic dilation leading to potential dissection and wall rupture. No causal treatment for the disease is available and current medical treatment is aimed at slowing aortic disease progression to minimize severe complications. When indicated, surgical repair of the aortic defect is performed. Although these strategies have clearly led to improved survival, some patients still present with fatal complications.
Cite
CITATION STYLE
Sips, P. Y., Le Roux, R., Caboor, L., Vermassen, P., Mennens, L., & De Backer, J. (2021). Characterizing the cardiovascular phenotype of a new zebrafish model of Marfan syndrome. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.3379
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.